Kota, Rajasthan | July 29, 2025 – In a groundbreaking advancement in ocular pharmacology, Dr. Suresh K. Pandey of SuVi Eye Hospital, Kota, has achieved a significant medical milestone by performing a successful toric IPCL (phakic lens) implantation using Mydricare XL PFS solution reportedly for the first time in the world during such a procedure.
This innovative solution, developed by Care Group India, contains tropicamide, phenylephrine, and lignocaine hydrochloride, enabling immediate pupillary dilation along with intracameral anesthesia. Its use completely eliminates the need for conventional preoperative dilating eye drops.
Key Highlights of the Surgery:
- Date: July 29, 2025
- Surgeon: Dr. Suresh K. Pandey
- Location: SuVi Eye Hospital, Kota
- Procedure: Toric IPCL implantation for myopia correction
- Innovation: Use of Mydricare XL PFS solution for intraoperative pupillary dilation
- Outcome: Quick, comfortable, and drop-free surgical experience
This successful case represents a pivotal moment in the evolution of dropless ophthalmic surgeries. Mydricare XL PFS not only simplified the preoperative process but also enhanced patient safety and comfort by delivering:
- Instant pupil dilation
- Intracameral anesthesia
- Elimination of multiple topical drops
- Reduced surgical preparation time
According to Dr. Pandey, “We are witnessing the future of eye surgery—one where traditional eye drops may no longer be necessary. This innovation brings us closer to fully dropless cataract and phakic implant surgeries.”
With this achievement, SuVi Eye Hospital reinforces its position at the forefront of modern eye care in India, embracing cutting-edge technologies that improve patient outcomes and surgical precision.
